Dr. Narkhede is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1720 2nd Avenue South
NP2540F North Pavilion
Birmingham, AL 35294Phone+1 205-934-2248Fax+1 949-698-6272- Is this information wrong?
Education & Training
- MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2016 - 2019
- Cleveland Clinic FoundationResidency, Internal Medicine, 2014 - 2016
- Cleveland Clinic FoundationInternship, Internal Medicine, 2013 - 2014
- KJ Somaiya Medical CollegeClass of 2006
Certifications & Licensure
- AL State Medical License 2019 - 2024
- DC State Medical License 2016 - 2020
- OH State Medical License 2013 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy Start of enrollment: 2021 Nov 15
Roles: Principal Investigator, Contact
- Addition of Loncastuximab Tesirine to Acalbrutinib , Chronic Lymphocytic Leukemia Start of enrollment: 2023 Dec 18
Roles: Sponsor-Investigator, Principal Investigator, Contact
- PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCL Start of enrollment: 2024 Jun 30
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Dosage of high-dose methotrexate as CNS prophylaxis in DLBCL: A detailed analysis of toxicity and impact on CNS relapse.Matthew R Wilson, Amy A Kirkwood, Nicole Wong Doo, Carole Soussain, Sylvain Choquet, Charlotte Lees, Christopher Fox, Gavin Preston, Matthew Ahearne, Tim Strüßmann, Al...> ;American Journal of Hematology. 2024 Feb 1
- 4 citationsNCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, Ranjana H Advani, Babis Andreadis, Nancy L Bartlett, L Elizabeth Budde, Paolo F Caimi, Julie E Chang, Beth Christia...> ;Journal of the National Comprehensive Cancer Network. 2023 Nov 1
- 2 citationsExposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study.Kai Qin, Kazuhito Honjo, Scott Sherrill-Mix, Weimin Liu, Regina M Stoltz, Allisa K Oman, Lucinda A Hall, Ran Li, Sarah Sterrett, Ellen R Frederick, Jeffrey R Lancaster...> ;Plos Medicine. 2023 Jun 1
- Join now to see all
Lectures
- Lack of Prognostic Significance of Pre-Treatment Total Metabolic Tumor Volume (TMTV) in Diffuse Large B-Cell Lymphoma (DLBCL)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- External Validation and Revision of Thrombosis Lymphoma /Throly/ Score2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Other Languages
- Hindi
Hospital Affiliations
- University of Alabama HospitalBirmingham, Alabama
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: